Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Squamous Cell

Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.

1,631 public trials 442 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Squamous Cell trial results

Completed

A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors

NCT05538572

Conditions
Adenoma, Astrocytoma, Breast Cancer, +43 more
Locations
  • Smilow Cancer Hospital Phase 1 Unit New Haven, Connecticut, United States
  • AdventHealth Medical Group Oncology Research at Celebration Celebration, Florida, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 13 locations
View Trial Details
Completed

Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

NCT05578820

Conditions
Anus Diseases, Anus Neoplasms, Breast Diseases, +47 more
Locations
  • GBUZ Moscow Clinical Scientific Center named after Loginov MHD Moscow, Russia
  • FSBI N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia Moscow, Russia
  • FSBI National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Health of Russia Moscow, Russia
  • National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation Moscow, Russia
View Trial Details
Completed

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

NCT04641871

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Squamous Cell, +20 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View all 17 locations
View Trial Details
Completed

Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy

NCT03719690

Conditions
Carcinoma, Carcinoma, Squamous Cell, HNSCC, +7 more
Locations
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA - Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • The Oncology Institute of Hope and Innovation - Anaheim Whittier, California, United States
View all 102 locations
View Trial Details
Completed

Phase 1 Study of BAY1905254 - An Early Clinical Research Study to Evaluate a New Drug Called Bapotulimab (BAY1905254) in the Expansion Cohort in Combination With Pembrolizumab in Head and Neck Cancer That Has Returned or is Discovered to be Metastatic and is Expressing PDL1.

NCT03666273

Conditions
Advanced Solid Tumor, Carcinoma, Carcinoma, Squamous Cell, +8 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • University of Chicago Hospitals Chicago, Illinois, United States
  • Henry Ford Health System Detroit, Michigan, United States
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies

NCT03629756

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • Scottsdale Healthcare Hospitals dba HonorHealth Scottsdale, Arizona, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Rocky Mountain Cancer Centers (Midtown) Denver, Colorado, United States
View all 15 locations
View Trial Details

Related conditions